INTRODUCTION
Activation of opioid receptors has generally been considered to have inhibitory effects on neuronal post-receptor events (North, 1989; Childers, 1991) . However, opioids also have excitatory effects on neuronal activity (Crain and Shen, 1990) . For example, it has been shown that opioids can stimulate 3',5'-cyclic adenosine monophosphate (cAMP) formation via a pertussis toxin-sensitive G-protein in neuronal cells from the rat olfactory bulb (Olianas and Onali, 1993) . Furthermore, we have recently reported that, in SH-SY5Y human neuroblastoma cells, ,u-opioids cause a transient, monophasic increase in inositol 1,4,5-trisphosphate [Ins(1, 4, 5) P3] formation, which involves a pertussis toxin-sensitive G-protein and is blocked by Ni2l (Smart et al., 1994a) .
One possible mechanism for this stimulation of Ins(l,4,5)P3
formation by opioids is that f/y subunits from G,/G. could activate a Ca2l-sensitive isoform of phospholipase C (PLC) such as PLC,f2 or PLCfl3 (Camps et al., 1992; Carozzi et al., 1993) .
However, only activation of the ,t-opioid receptor in SH-SY5Y cells stimulates Ins(1,4,5)P3 formation (Smart et al., 1994a ), yet both ,u-and 6-opioid receptors couple to GV. Since there are 2-5-fold more ,u than a (and no K) receptors in these cells (Yu et al., 1986) , d-receptor activation may not liberate sufficent //y subunits to activate PLC. SH-SY5Y cells also express a2
adrenoceptors, which couple via Gi to inhibit adenylate cyclase activity (Lambert and Nahorski, 1990a) . Levels of a2 expression are similar to those of the 8-opioid receptor.
Alternatively, the Is-opioid receptor could mediate the opening of a Ca2+ channel, allowing Ca2+-influx-dependent activation of a Ca2+-sensitive isoform of PLC. SH-SY5Y cells possess both Land N-type voltage-sensitive Ca2+ channels (VSCC) (Toselli et al., 1991; Morton et al., 1992) open VSCCs in NG108-15 cells and astrocytes (Jin et al., 1992; Eriksson et al., 1993) , although it should be emphasized that opioids generally close VSCCs (Porzig, 1990) . In this study we have addressed both of these hypotheses. First, we increased the intracellular concentration of/J/y subunits from G1 by selective activation of ,u-, d-and ac2-receptors. Secondly, we further characterized the Ca2l dependency of the ,uopioid stimulation of Ins(1,4,5)P3 formation. We have shown that, in SH-SY5Y cells, activation of the ,t-opioid receptor allows Ca2+ influx to activate PLC.
MATERIALS AND METHODS
Cell culture and harvesting SH-SYSY human neuroblastoma cells (passages 70-90) were cultured in Minimum Essential Medium with Earle's salts supplemented with 2 mM L-glutamine, 100 i.u./ml penicillin, 100,ug/ml streptomycin, 2.5 ,tg/ml fungizone, and 100% fetal calf serum (GIBCO, U.K.).
Cells were harvested with 10 mM Hepes-buffered saline/ 0.02 % EDTA, pH 7.4, washed twice with, and then resuspended (final volume 0.3 ml) in, Krebs/Hepes buffer, pH 7.4, of the following composition (in mM), unless stated otherwise below: Na+, 143.3; K+, 4.7; Ca21, 2.5; Mg2+, 1.2; 125.6; HCO; , 25; 1.2; 1.2; glucose, 11.7; and Hepes, 10. Measurement of lns(1,4,5)P3
Whole-cell suspensions (0.3 ml) were preincubated at 37°C in Ca2+-containing or Ca2+-free buffer, with or without naloxone (1 ,uM), atropine (1 ,uM) for 0-300 s. In some studies, cells were suspended in Ca2+-free buffer 1-2 min before incubation with fentanyl (0.1 tM) and the Ca2+ (2.5 mM) subsequently replaced (1-11 min later). Reactions were terminated by the addition of 0.3 ml of 1 M trichloroacetic acid.
Ins(1,4,5)P3 was extracted with Freon/octylamine (1:1, v/v) and neutralized with 25 mM NaHCO0. Ins(1,4,5)P3 was assayed using a bovine adrenocortical binding protein and [3H]-Ins(1,4,5)P3 (41 Ci/mol; Amersham, U.K.) at 4 'C. Authentic Ins(1,4,5)P3 (0.036-12 pmol; Siemat, U.K.) in buffer, taken through an identical extraction process, was used as a standard. Non-specific binding was defined in the presence of excess Ins(1,4,5)P3 (0.3 nmol). Bound [3H]Ins(1,4,5)P3 was separated by rapid vacuum filtration (Challiss et al., 1988) .
Measurement of cAMP
Whole-cell suspensions (0.3 ml) were incubated in the presence of isobutylmethylxanthine (IBMX) (1 mM), with or without fentanyl (1 ,uM) at 37 'C for 0-300 s. Reactions were terminated by the addition of 20 ,ul of HCI (10 M), 20 ,1 of NaOH (lOM), and 180 ,d1 of Tris (1 M, pH 7.5). The concentration of cAMP was measured in the supernatants by a specific radiolabelled receptor assay, as described previously (Brown et al., 1971 ).
Data analysis
All data are given as mean + S.E.M. unless otherwise stated, and are shown as primary data (pmol/mg of protein) throughout, although some variation between passages does occur. EC50
(half-maximal stimulation) and IC50 (half-maximal inhibition) values were obtained by computer-assisted curve fitting using GRAPHPAD. Statistical comparisons made where appropriate by Student's t-test (paired or unpaired) and/or ANOVA and were considered significant when P < 0.05. RESULTS Fentanyl (0.1 tM) caused a monophasic increase in Ins(1,4,5)P3 formation, which peaked (26.5 + 3.6 pmol/mg of protein) at 15 s and returned to basal levels (6.0 + 0.5 pmol/mg of protein) between 1 and 2 min (Figure 1 ), as previously reported (Smart et al., 1994a) . In contrast, fentanyl (1 ,uM) inhibited cAMP formation, with maximum inhibition (40%) occurring in 30 s and being maintained as long as the agonist remained on the receptor (Figure 1 ), although it should be noted that phosphodiesterase activity was inhibited with IBMX. DAMGO (1 ,uM) stimulated Ins(1,4,5)P, formation at 15 s, while DPDPE (10 ,uM) and clonidine (1 ,uM), alone or in combination, did not (Table 1) Fentanyl (0.1 ,uM) had no effect on Ins(1,4,5)P3 formation in Ca2+-free buffer, as previously reported (Smart et al., 1994a) . However, when Ca2+ (2.5 mM) was replaced 1 min after the fentanyl challenge, there was a subsequent substantial stimulation of Ins(1,4,5)P3 formation (Figure 2 ). This response was timedependent as, while Ca2+ replacement at 2 min caused a small but Cell suspensions (0.3 ml) were incubated with fentanyl (0.1 #M) for 0-300 s. Ins(1,4,5)P3 and cAMP were measured by specific radio-receptor mass assays. Data are mean + S.E.M., where n = 3. Whole curves for Ins(1,4,5)P3 formation (V) and cAMP formation (E) are P < 0.05 by ANOVA. * denotes P < 0.05 (ttest) increased compared with basal, and ** denotes P < 0.05 (ttest) decreased compared with basal. (Figure 4 ), which rose from basal (12.8 + 1.2 pmol/mg of protein) to a peak (8.2-fold basal) at 10 s and then declined until 60 s to a steady plateau phase (1.8-fold basal) which was maintained until sampling ended (300 s). Basal Ins(1,4,5)P3 did not change over the 300 s time course (Figure 4 and data not shown). The peak phase, which releases Ca2+ from the intracellular stores, is Ca2+ independent, while the plateau phase, which may or may not release Ca2 , is dependent on the influx of extracellular Ca2+ (Lambert and Nahorski, 1990b) , via non-voltage-sensitive Ca2+ channels (Lambert et al., 1990) .
Fentanyl (0.1 1uM) enhanced carbachol-induced Ins(1,4,5)P3 formation at both the peak (by 20.8 pmol/mg of protein) and plateau (by 16.0 pmol/mg of protein) phases (Figure 4) (Berridge, 1993) . Moreover, it has been proposed that Ins(1,4,5)P3-induced rises in intracellular Ca2+ concentrations ([Ca2+] ,) increase K+ efflux, and thus cause hyperpolarization, and that this may be one of the mechanisms underlying morphine analgesia (Lipp, 1991 ).
In the current study, fentanyl stimulated Ins(1,4,5)P3 formation and inhibited cAMP formation. While opioids are generally (North, 1989) , excitatory actions, such as depolarization and increased neurotransmitter release, have also been reported (Crain and Shen, 1990) . Opioids usually inhibit cAMP formation (as confirmed here) and have little or no effect on Ins(1,4,5)P3 formation (Childers, 1991) , but opioid-induced stimulation of the production of both second messengers in neuronal tissues has recently been reported (Olianas and Onali, 1993; Smart et al., 1994a) . Noteably, in this study fentanyl, over the same dose range, stimulated one second messenger while inhibiting the other. Although dual excitatory and inhibitory effects of opioids in neuronal tissue have been reported previously (Higashi et al., 1982; Jin et al., 1992) , the type of effect seen depended on the dose of opioid used. For example, in NG108-15 cells nanomolar concentrations of 6-opioids increased [Ca2l] ,, while at micromolar concentrations they decreased [Ca2l], (Jin et al., 1992) . Taken at face value our data showing stimulation ofIns(l,4,5)P3 formation and inhibition of cAMP turnover suggest that the ,t-opioid receptor on SH-SY5Y cells is exhibiting G-protein promiscuity. In a recent report Johnson et al. (1994) described in COS cells transiently expressing the cloned opioid receptor ,aORl, that promiscuity may occur to cAMP inhibition and inhibition of Ins(1,4,5)P3 formation. However, our previous studies indicate that both events in SH-SY5Y cells are mediated by a pertussis toxin-sensitive G-protein (Smart et al., 1994a) , implying Gprotein fidelity. Clearly, further studies will be required to settle this issue, using titratable levels of cloned receptors at close to endogenous concentrations. Neither 6-opioid nor a2 agonists stimulated Ins(1,4,5)P3 formation, while the,-opioid agonist DAMGO did (Table 1. ). It is worth noting that SH-SY5Y cells do not express K-opioid receptors (Yu et al., 1986) . Furthermore, neither 1-opioid nor a2 agonists enhanced the Ins(1,4,5)P3 response to a submaximal dose of DAMGO, ruling out the possibility that insufficent ,/y subunits were liberated to have a stimulatory effect. Therefore, as all three of these receptors couple to Gi (Yu et al., 1986; Lambert and Nahorski, 1990a) , this indicates that fl/y-subunit activation of PLC, as seen in other cell types (Birnbaumer, 1992) , is unlikely to occur in SH-SY5Y cells. However, , couple to different subtypes of Gi in SH-SY5Y cells (Laugwitz et al., 1993) , and they may also couple differentially to Go, as in rat cortical membranes where the two receptor subtypes couple to different types of Go (Moriaty et al., 1990; Georgoussi et al., 1993) . Thus, as the type of fl/y subunit varies between G-protein subtypes (Pronin and Gautam, 1992) , and some reports indicate that fl/y-determined signal transduction is selective (Kleuss et al., 1993) , there remains the possibility that f/y subunits are involved in the stimulatory effects of,u-opioids in SH-SY5Y cells.
Fentanyl did not increase Ins(1,4,5)P3 formation in Ca2+-free conditions, as previously reported (Smart et al., 1994a) , but subsequent Ca2' replacement at 1 min restored the stimulatory effect. This suggests that,u-opioids may open a Ca2+ channel, and that the subsequent Ca2+ influx activates PLC (Cockcroft and Thomas, 1992; Rhee and Choi, 1992) . Indeed, it has recently been shown that Ca2+ activates the PLC isoform 81 in transfected Chinese hamster ovary cells (Banno et al., 1994) . While opioids generally close Ca2+ channels (Porzig, 1990) , there is evidence that they can also open Ca2+ channels, as seen with &-opioids in NG108-15 cells (Jin et al., 1992 Figure 2) . Such rapid desensitization may result from receptor phosphorylation, although other mechanisms are possible (Lohse, 1993; Inglese et al., 1993) .
There are several types of VSCCs (denoted L, N, T and P), each of which have different electrophysical and pharmacological properties, as well as receptor-operated Ca2l channels (ROCC) (for review see Spedding and Paoletti, 1992) . SH-SY5Y cells possess L-and N-type VSCCs (Toselli et al., 1991; Morton et al., 1992) , as well as ROCCs mediating carbachol-induced Ca2+ entry, which is not sensitive to either dihydropyridines or conotoxins (Lambert et al., 1990) . Nifedipine completely inhibited the fentanyl-induced Ins(1,4,5)P3 response, indicating that,-opioids may open an L-type VSCC (Spedding and Paoletti, 1992) . This is in agreement with a recent study which showed Kopioids opened L-type VSCCs in astrocytes (Eriksson et al., 1993) . Furthermore, nifedipine antagonized morphine-induced analgesia in mice (Contreras et al., 1988) , although this has been disputed (Omote et al., 1993; Wong et al., 1993) . It is worth noting here that the ,t-opioid stimulation of Ins(1,4,5)P3 formation involves a pertussis toxin-sensitive G-protein (Smart et al., 1994a) , and G-protein activation has been linked to Ca2+-channel opening (Dolphin and Scott, 1989) .
Fentanyl caused a dose-dependent enhancement of carbacholinduced Ins(1,4,5)P3 formation. In addition, opioids enhanced Ins(1,4,5)P3 formation induced by low doses (1-10 nM) of bradykinin in NG108-15 cells (Okajima et al., 1993) . In contrast, in chromaffin cells opioids had no effect on muscarinic-induced total [3H]inositol polyphosphate accumulation (Bunn et al., 1988) , although it should be noted that this method was also unable to detect the opioid-induced increase in Ins(1,4,5)P3 formation in SH-SY5Y cells (Smart et al., 1994a) . This enhancement of muscarinic-induced Ins(1,4,5)P3 formation by ,uopioids was additive (Table 2) , unlike the synergistic enhancement of corticotrophin-releasing hormone-induced cAMP formation by opioids in the rat olfactory bulb (Olianas and Onali, 1993) , suggesting that in SH-SY5Y cells the ,u-opioid and the M3 muscarinic receptor utilize the same pool of phosphoinositides. The enhancement of Ins(1,4,5)P3 formation was not caused by changes in either opioid or muscarinic binding, as the affinities for both carbachol and fentanyl were unchanged (Smart et al., 1994a,b) , even though fentanyl has been reported to be a very weak muscarinic antagonist (Hustveit and Setekleiv, 1993; Atcheson et al., 1994) .
There are many studies showing an opioid receptor-mediated reduction in neurotransmitter release (see North, 1989) , and this is generally believed to be the process underlying analgesia. However, we have previously shown in SH-SY5Y cells that, while ,u-opioid receptor occupation reduced cAMP formation, there was no opioid-receptor-mediated inhibition of [3H]noradrenaline release (Lambert et al., 1993; Atcheson et al., 1994) . Moreover, in perfused SH-SY5Y cells in the present study, fentanyl (50 nM) failed to stimulate noradrenaline release (results not shown). This clearly indicates that the presumed increase in
[Ca2+]i associated with ,u-opioid receptor occupancy may not be sufficient to activate the secretory mechanisms. The functional role of this brief Ca2+ influx is unclear, but may be an early warning of incoming noxious stimuli or could act as a trigger to hyperpolarization.
In conclusion, we report here that activation of the ,u-opioid receptor briefly allows Ca2+ influx, posssibly via L-type Ca2+ channels, which stimulates PLC, leading to a transient increase in Ins(1,4,5)P3 formation, in SH-SY5Y human neuroblastoma cells. Furthermore, activation of this system can enhance muscarinic-induced PLC activity by a post-receptor mechanism. However, the possible role of this mechanism in the process of analgesia still remains unclear.
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